GSK, Hansoh ADC extends survival in lung cancer study

Friday, July 10, 2026Delilah AlvaradoView original

GSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among cancer drugmakers.

Read the full article on the original site.